Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938422897> ?p ?o ?g. }
- W2938422897 endingPage "350" @default.
- W2938422897 startingPage "350" @default.
- W2938422897 abstract "Glioma is the most common primary tumor of the nervous system, and approximately 50% of patients exhibit the most aggressive form of the cancer, glioblastoma. The biological function of epidermal growth factor receptor (EGFR) in tumorigenesis and progression has been established in various types of cancers, since it is overexpressed, mutated, or dysregulated. Its overexpression has been shown to be associated with enhanced metastatic potential in glioblastoma, with EGFR at the top of a downstream signaling cascade that controls basic functional properties of glioblastoma cells such as survival, cell proliferation, and migration. Thus, EGFR is considered as an important therapeutic target in glioblastoma. Many anti-EGFR therapies have been investigated both in vivo and in vitro, making their way to clinical studies. However, in clinical trials, the potential efficacy of anti-EGFR therapies is low, primarily because of chemoresistance. Currently, a range of epigenetic drugs including histone deacetylase (HDAC) inhibitors, DNA methylation and histone inhibitors, microRNA, and different types of EGFR inhibitor molecules are being actively investigated in glioblastoma patients as therapeutic strategies. Here, we describe recent knowledge on the signaling pathways mediated by EGFR/EGFR variant III (EGFRvIII) with regard to current therapeutic strategies to target EGFR/EGFRvIII amplified glioblastoma." @default.
- W2938422897 created "2019-04-25" @default.
- W2938422897 creator A5009304661 @default.
- W2938422897 creator A5038309273 @default.
- W2938422897 creator A5038592450 @default.
- W2938422897 creator A5046447304 @default.
- W2938422897 creator A5061369541 @default.
- W2938422897 date "2019-04-12" @default.
- W2938422897 modified "2023-10-16" @default.
- W2938422897 title "Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma" @default.
- W2938422897 cites W131042380 @default.
- W2938422897 cites W143763378 @default.
- W2938422897 cites W144423133 @default.
- W2938422897 cites W1488900815 @default.
- W2938422897 cites W1575973365 @default.
- W2938422897 cites W1754197334 @default.
- W2938422897 cites W1821845209 @default.
- W2938422897 cites W1837617056 @default.
- W2938422897 cites W1870193477 @default.
- W2938422897 cites W1963558982 @default.
- W2938422897 cites W1965073022 @default.
- W2938422897 cites W1966188939 @default.
- W2938422897 cites W1967018540 @default.
- W2938422897 cites W1969201755 @default.
- W2938422897 cites W1969731848 @default.
- W2938422897 cites W1972587317 @default.
- W2938422897 cites W1973507557 @default.
- W2938422897 cites W1975104842 @default.
- W2938422897 cites W1975705914 @default.
- W2938422897 cites W1975989411 @default.
- W2938422897 cites W1975990978 @default.
- W2938422897 cites W1978756138 @default.
- W2938422897 cites W1979872480 @default.
- W2938422897 cites W1980883466 @default.
- W2938422897 cites W1980937575 @default.
- W2938422897 cites W1982255060 @default.
- W2938422897 cites W1984960581 @default.
- W2938422897 cites W1985292554 @default.
- W2938422897 cites W1986042985 @default.
- W2938422897 cites W1986092833 @default.
- W2938422897 cites W1986303437 @default.
- W2938422897 cites W1988442325 @default.
- W2938422897 cites W1989973431 @default.
- W2938422897 cites W1990079648 @default.
- W2938422897 cites W1990736053 @default.
- W2938422897 cites W1994659747 @default.
- W2938422897 cites W1994915239 @default.
- W2938422897 cites W1995197723 @default.
- W2938422897 cites W1995502732 @default.
- W2938422897 cites W2003189290 @default.
- W2938422897 cites W2005036868 @default.
- W2938422897 cites W2006776134 @default.
- W2938422897 cites W2007073167 @default.
- W2938422897 cites W2007965086 @default.
- W2938422897 cites W2008320487 @default.
- W2938422897 cites W2009063639 @default.
- W2938422897 cites W2009886463 @default.
- W2938422897 cites W2014031706 @default.
- W2938422897 cites W2019785182 @default.
- W2938422897 cites W2020702689 @default.
- W2938422897 cites W2028152601 @default.
- W2938422897 cites W2034852369 @default.
- W2938422897 cites W2038419703 @default.
- W2938422897 cites W2044805735 @default.
- W2938422897 cites W2045477218 @default.
- W2938422897 cites W2047781274 @default.
- W2938422897 cites W2048260140 @default.
- W2938422897 cites W2048919107 @default.
- W2938422897 cites W2049018701 @default.
- W2938422897 cites W2049720180 @default.
- W2938422897 cites W2052341898 @default.
- W2938422897 cites W2057144418 @default.
- W2938422897 cites W2058273658 @default.
- W2938422897 cites W2066066481 @default.
- W2938422897 cites W2066264051 @default.
- W2938422897 cites W2068915942 @default.
- W2938422897 cites W2071067115 @default.
- W2938422897 cites W2071559249 @default.
- W2938422897 cites W2074664629 @default.
- W2938422897 cites W2074885018 @default.
- W2938422897 cites W2075611357 @default.
- W2938422897 cites W2078383448 @default.
- W2938422897 cites W2078901327 @default.
- W2938422897 cites W2081980323 @default.
- W2938422897 cites W2083836886 @default.
- W2938422897 cites W2084278966 @default.
- W2938422897 cites W2086216067 @default.
- W2938422897 cites W2086564214 @default.
- W2938422897 cites W2087751682 @default.
- W2938422897 cites W2087861588 @default.
- W2938422897 cites W2087891885 @default.
- W2938422897 cites W2089913110 @default.
- W2938422897 cites W2093177681 @default.
- W2938422897 cites W2094709780 @default.
- W2938422897 cites W2094963389 @default.
- W2938422897 cites W2096287682 @default.
- W2938422897 cites W2097097666 @default.
- W2938422897 cites W2098440278 @default.